Industry News
Novogen reaches cancer drug milestone
Novogen (ASX:NRT) has revealed that one enantiomer of cancer drug candidate CS-6 appears many times more active against brain cancer than the reverse form. [ + ]
Clinuvel’s EU application for Scenesse delayed
The EMA has allocated more time to review Clinuvel’s (ASX:CUV) application for approval of Scenesse as an EPP treatment. [ + ]
Australia’s first Biohackathon
A Biohackathon will open up scientific problem solving to the public next week in Sydney. [ + ]
Four more surgeons cleared to use CardioCel
Allied Healthcare (ASX:AHZ) says five surgeons have now received early approval to use heart patch CardioCel under the TGA’s Authorized Prescriber Scheme. [ + ]
Company evaluating pSivida eye drug insert tech
A company is evaluating using pSivida’s (ASX:PVA) eye drug delivery technologies Durasert and Tethadur for its own ophthalmic drug products. [ + ]
Applikon to buy HaloteC’s biotech portfolio
Applikon Biotechnology will buy part of the product portfolio of HaloteC Instruments and integrate the instruments and software tech into its bioreactor software offerings. [ + ]
Record funding for cancer research in the west
The Cancer Council of Western Australia recently allocated $2.8 million in annual funding for research in Western Australia. [ + ]
Alchemia granted oncology patent extension
The US patent office has granted Alchemia (ASX:ACL) an extension for a key patent covering its HyACT oncology platform through to 2025. [ + ]
Agricultural research receives funding
Australian farmers are set to benefit from 31 new research projects that will look at adapting farming practices to reduce carbon emissions and earn them an income by generating and selling carbon credits. [ + ]
Alchemia anticoagulant launches in India
Alchemia’s (ASX:ACL) marketing partner, Dr Reddy’s, has launched generic fondaparinux in India, marking its debut in a market outside of the US. [ + ]
$100 million allocated for new tranche of investment fund
As part of the federal government’s recently announced industry and innovation plan ‘A Plan for Australian Jobs’, in which it announced a new $350 million round of the Innovation Investment Fund (IIF), $100 million has now been allocated. [ + ]
2013 Medical Device Commercialisation Seminar Series starts today
The 2013 Medical Device Commercialisation Seminar Series explores what it takes to be one of the medical device success stories, helping today’s inventors fast-track to commercialisation. [ + ]
In search of outstanding glass researchers
The Otto Schott Research Award, bestowed for the first time in 1991, honours outstanding scientific achievements in the field of international glass research every two years. [ + ]
Applikon Biotechnology acquires biotech portfolio from HaloteC Instruments
Bioreactor systems company Applikon Biotechnology has signed a definitive agreement to acquire the biotechnology portfolio of HaloteC Instruments, a Dutch provider of instruments and software solutions for the biotech market. [ + ]
Up to $10 million in cancer research funding available through ACRF
The Australian Cancer Research Foundation (ACRF) has begun accepting applications for their 2013 annual Cancer Research Grant Round. [ + ]
